These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1163 related articles for article (PubMed ID: 9517643)

  • 21. [The prevalence of atrophic gastritis and intestinal metaplasia according to gender, age and Helicobacter pylori infection in a rural population].
    Kim HJ; Choi BY; Byun TJ; Eun CS; Song KS; Kim YS; Han DS
    J Prev Med Public Health; 2008 Nov; 41(6):373-9. PubMed ID: 19037166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori and atrophic gastritis: importance of the cagA status.
    Kuipers EJ; Pérez-Pérez GI; Meuwissen SG; Blaser MJ
    J Natl Cancer Inst; 1995 Dec; 87(23):1777-80. PubMed ID: 7473834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection.
    Beales IL; Crabtree JE; Scunes D; Covacci A; Calam J
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):645-9. PubMed ID: 8853252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [CagA status and virulence of Helicobacter pylori strains. Results of a French multicentric prospective study].
    Bommelaer G; Bruley Des Varannes S; Fléjou JF; Matysiak T; Poynard T; Richard A; Slama A; Mégraud F;
    Gastroenterol Clin Biol; 2001 Dec; 25(12):1084-9. PubMed ID: 11910990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoking, Helicobacter pylori virulence, and type of intestinal metaplasia in Portuguese males.
    Peleteiro B; Lunet N; Figueiredo C; Carneiro F; David L; Barros H
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):322-6. PubMed ID: 17301266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
    Arkkila PE; Seppälä K; Färkkilä MA; Veijola L; Sipponen P
    Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis.
    Annibale B; Lahner E; Santucci A; Vaira D; Pasquali A; Severi C; Mini R; Figura N; Delle Fave G
    Helicobacter; 2007 Feb; 12(1):23-30. PubMed ID: 17241297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies reacting with gastric antigens in Helicobacter pylori associated body gastritis of dyspeptic children.
    Ierardi E; Francavilla R; Balzano T; Negrini R; Francavilla A
    Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):478-80. PubMed ID: 9836099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dominant cagA/vacA genotypes and coinfection frequency of H. pylori in peptic ulcer or chronic gastritis patients in Zhejiang Province and correlations among different genotypes, coinfection and severity of the diseases.
    Chen XJ; Yan J; Shen YF
    Chin Med J (Engl); 2005 Mar; 118(6):460-7. PubMed ID: 15788126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study.
    Anderson LA; Murphy SJ; Johnston BT; Watson RG; Ferguson HR; Bamford KB; Ghazy A; McCarron P; McGuigan J; Reynolds JV; Comber H; Murray LJ
    Gut; 2008 Jun; 57(6):734-9. PubMed ID: 18025067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
    Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
    Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
    Toyokawa T; Suwaki K; Miyake Y; Nakatsu M; Ando M
    J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P; Ranta P; Helske T; Kääriäinen I; Mäki T; Linnala A; Suovaniemi O; Alanko A; Härkönen M
    Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
    J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate.
    Ferrández A; Benito R; Arenas J; García-González MA; Sopeña F; Alcedo J; Ortego J; Sainz R; Lanas A
    BMC Gastroenterol; 2006 Feb; 6():7. PubMed ID: 16483364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The humoral immuneresponse to Helicobacter pylori infection in children with gastrointestinal symptoms.
    Janulaityte-Gunther D; Kucinskiene R; Kupcinskas L; Pavilonis A; Labanauskas L; Cizauskas A; Schmidt U; Wadström T; Andersen LP
    FEMS Immunol Med Microbiol; 2005 May; 44(2):205-12. PubMed ID: 15866217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection.
    Lahner E; Bordi C; Cattaruzza MS; Iannoni C; Milione M; Delle Fave G; Annibale B
    Aliment Pharmacol Ther; 2005 Sep; 22(5):471-81. PubMed ID: 16128686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Helicobacter pylori in gastric carcinoma.
    Prabhu SR; Amrapurkar AD; Amrapurkar DN
    Natl Med J India; 1995; 8(2):58-60. PubMed ID: 7735060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.
    Kuipers EJ; Uyterlinde AM; Peña AS; Hazenberg HJ; Bloemena E; Lindeman J; Klinkenberg-Knol EC; Meuwissen SG
    Am J Gastroenterol; 1995 Sep; 90(9):1401-6. PubMed ID: 7661157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.